Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.
Horneff, Gerd
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. [electronic resource] - Annals of the rheumatic diseases Jun 2014 - 1114-22 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1468-2060
10.1136/annrheumdis-2012-203046 doi
Adolescent
Antirheumatic Agents--therapeutic use
Arthritis, Juvenile--drug therapy
Arthritis, Psoriatic--drug therapy
Child
Child, Preschool
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Male
Receptors, Tumor Necrosis Factor--therapeutic use
Severity of Illness Index
Treatment Outcome
Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. [electronic resource] - Annals of the rheumatic diseases Jun 2014 - 1114-22 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1468-2060
10.1136/annrheumdis-2012-203046 doi
Adolescent
Antirheumatic Agents--therapeutic use
Arthritis, Juvenile--drug therapy
Arthritis, Psoriatic--drug therapy
Child
Child, Preschool
Etanercept
Female
Humans
Immunoglobulin G--therapeutic use
Male
Receptors, Tumor Necrosis Factor--therapeutic use
Severity of Illness Index
Treatment Outcome